Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 431501 - 431520 out of 485545 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Sweden | (G04BD10) darifenacin | Emselex® | 98, 7,5 mg , Blister, 98 tabletter (PVC/PVDC/Al) (PD 2 Care 4) | Retail price without vat |
$0-0 |
$0-0 |
Urinary Incontinence, Urge; Urinary Bladder, Overactive | 2care4ApS |
| Sweden | (G04BD12) mirabegron | Betmiga | 30, 25 mg , Blister, 30 tabletter (PD Medartuum AB) | Retail price without vat |
$0-0 |
$0-0 |
Urinary Bladder, Overactive | MedartuumAB |
| Sweden | (G04BD12) mirabegron | Betmiga | 90, 25 mg , Blister, 90 tabletter (PD Medartuum AB) | Retail price without vat |
$0-0 |
$0-0 |
Urinary Bladder, Overactive | MedartuumAB |
| Sweden | (G04BD12) mirabegron | Betmiga | 30, 25 mg , Blister, 30 tabletter (PD 2 Care 4) | Retail price without vat |
$0-0 |
$0-0 |
Urinary Bladder, Overactive | 2care4ApS |
| Sweden | (G04BD12) mirabegron | Betmiga | 90, 25 mg , Blister, 90 tabletter (PD 2 Care 4) | Retail price without vat |
$0-0 |
$0-0 |
Urinary Bladder, Overactive | 2care4ApS |
| Sweden | (G04BD12) mirabegron | Betmiga | 30, 25 mg , Blister, 30 tabletter | Retail price without vat |
$0-0 |
$0-0 |
Urinary Bladder, Overactive | AstellasPharmaAB |
| Sweden | (G04BD12) mirabegron | Betmiga | 90, 25 mg , Blister, 90 tabletter | Retail price without vat |
$0-0 |
$0-0 |
Urinary Bladder, Overactive | AstellasPharmaAB |
| Sweden | (G04BD12) mirabegron | Betmiga | 90, 25 mg , Blister, 90 tabletter (PD Orifarm AB) | Retail price without vat |
$0-0 |
$0-0 |
Urinary Bladder, Overactive | OrifarmAB |
| Sweden | (G04BD12) mirabegron | Betmiga | 30, 25 mg , Blister, 30 tabletter (PD Paranova Läkemedel AB) | Retail price without vat |
$0-0 |
$0-0 |
Urinary Bladder, Overactive | ParanovaLäkemedelAB |
| Sweden | (G04BD12) mirabegron | Betmiga | 90, 25 mg , Blister, 90 tabletter (PD Paranova Läkemedel AB) | Retail price without vat |
$0-0 |
$0-0 |
Urinary Bladder, Overactive | ParanovaLäkemedelAB |
| Sweden | (G04BD12) mirabegron | Betmiga | 90, 25 mg , Blister, 90 tabletter (PD Abacus Medicine A/S) | Retail price without vat |
$0-0 |
$0-0 |
Urinary Bladder, Overactive | AbacusMedicineA/S |
| Sweden | (G04BD12) mirabegron | Betmiga | 90, 50 mg , Blister, 90 tabletter (PD Abacus Medicine A/S) | Retail price without vat |
$0-0 |
$0-0 |
Urinary Bladder, Overactive | AbacusMedicineA/S |
| Sweden | (G04BD12) mirabegron | Betmiga | 30, 50 mg , Blister, 30 tabletter | Retail price without vat |
$0-0 |
$0-0 |
Urinary Bladder, Overactive | AstellasPharmaAB |
| Sweden | (G04BD12) mirabegron | Betmiga | 90, 50 mg , Blister, 90 tabletter | Retail price without vat |
$0-0 |
$0-0 |
Urinary Bladder, Overactive | AstellasPharmaAB |
| Sweden | (G04BD12) mirabegron | Betmiga | 30, 50 mg , Blister, 30 tabletter (PD 2 Care 4) | Retail price without vat |
$0-0 |
$0-0 |
Urinary Bladder, Overactive | 2care4ApS |
| Sweden | (G04BD12) mirabegron | Betmiga | 90, 50 mg , Blister, 90 tabletter (PD 2 Care 4) | Retail price without vat |
$0-0 |
$0-0 |
Urinary Bladder, Overactive | 2care4ApS |
| Sweden | (G04BD12) mirabegron | Betmiga | 90, 50 mg , Blister, 90 tabletter (PD Medartuum AB) | Retail price without vat |
$0-0 |
$0-0 |
Urinary Bladder, Overactive | MedartuumAB |
| Sweden | (G04BD12) mirabegron | Betmiga | 30, 50 mg , Blister, 30 tabletter (PD Medartuum AB) | Retail price without vat |
$0-0 |
$0-0 |
Urinary Bladder, Overactive | MedartuumAB |
| Sweden | (G04BD12) mirabegron | Betmiga | 30, 50 mg , Blister, 30 tabletter (PD Orifarm AB) | Retail price without vat |
$0-0 |
$0-0 |
Urinary Bladder, Overactive | OrifarmAB |
| Sweden | (G04BD12) mirabegron | Betmiga | 90, 50 mg , Blister, 90 tabletter (PD Paranova Läkemedel AB) | Retail price without vat |
$0-0 |
$0-0 |
Urinary Bladder, Overactive | ParanovaLäkemedelAB |
Pages
